IP Library Granted Patent US 9,873,866
Granted Patent B2
US 9,873,866 · App. 15/414,291 · Granted Jan 23, 2018

Mutant dehalogenase proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,873,866
App. No.
15/414,291
Granted
Jan 23, 2018
Kind
B2
Abstract

The invention provides a mutant hydrolase protein with enhanced kinetics and functional expression, as well as polynucleotides encoding the mutant proteins and methods of using the polynucleotides and mutant proteins.

Claims (25)

1. An isolated polypeptide comprising a mutant dehalogenase that has dehalogenase activity and forms a covalent bond with a dehalogenase substrate, said mutant dehalogenase having at least 90% amino acid sequence identity to the polypeptide of SEQ ID NO: 1, wherein said mutant dehalogenase comprises substitutions corresponding to substitutions at:

(a) one or more positions corresponding to positions in SEQ ID NO:1 selected from the group consisting of positions 106 and 272; and

(b) one or more positions corresponding to positions in SEQ ID NO:1 selected from the group consisting of positions 58, 78, 155, 167, 172, 224, and 291.

2. The isolated polypeptide of claim 1 , wherein said mutant dehalogenase further comprises one or more substitutions at positions corresponding to positions in SEQ ID NO: 1 selected from the group consisting of positions 5, 7, 11, 12, 20, 30, 32, 47, 54, 55, 56, 60, 65, 80, 82, 87, 88, 94, 96, 109, 113, 116, 117, 118, 121, 124, 128, 131, 134, 136, 144, 147, 150, 151, 157, 160, 161, 164, 165, 180, 182, 183, 187, 195, 197, 204, 218, 221, 227, 231, 233, 250, 256, 257, 263, 264, 277, 280, 282, and 288.

3. The isolated polypeptide of claim 1 , wherein said mutant dehalogenase further comprises 5 or more substitutions at positions corresponding to positions in SEQ ID NO: 1 selected from the group consisting of positions 47, 87, 88, 128, 160, 195, 227, 257, and 264.

4. The isolated polypeptide of claim 1 , wherein said mutant dehalogenase further comprises 20 or more substitutions at positions corresponding to positions in SEQ ID NO: 1 selected from the group consisting of positions 5, 7, 11, 12, 20, 30, 32, 47, 54, 55, 56, 60, 65, 80, 82, 87, 88, 94, 96, 109, 113, 116, 117, 118, 121, 124, 128, 131, 134, 136, 144, 147, 150, 151, 157, 160, 161, 164, 165, 167, 180, 182, 183, 187, 195, 197, 204, 218, 221, 227, 231, 233, 250, 256, 257, 263, 264, 277, 280, 282, and 288 of SEQ ID NO:1.

5. A fusion polypeptide comprising the polypeptide of claim 1 and a polypeptide of interest.

6. The fusion polypeptide of claim 5 , wherein the polypeptide of interest is at the C-terminus of the fusion polypeptide.

7. The polypeptide of claim 5 , wherein the polypeptide of interest is at the N-terminus of the fusion polypeptide.

8. The polypeptide of claim 5 , further comprising a polypeptide linker linking the polypeptide of interest and the polypeptide of claim 1 .

9. The polypeptide of claim 8 , wherein the linker comprises a protease recognition sequence.

10. The polypeptide of claim 8 , wherein the linker comprises SEQ ID NO: 31 (EPTTEDLYFQS/C) or SEQ ID NO: 38 (EPTTEDLYFQS/CDN).

11. A solid support comprising the polypeptide of claim 1 .

12. A kit comprising: (a) a compound comprising a dehalogenase substrate of the formula R-linker-A-X, wherein R is a solid support, A-X is a substrate for the mutant dehalogenase in the polypeptide of claim 1 , X is a halogen, and the linker is a group that links A to the solid support; wherein R, linker, A, and X are covalently linked, and (b) the polypeptide of claim 1 .

13. The kit of claim 12 , wherein A is (CH 2 ) n and n=4 to 10.

14. The kit of claim 12 , wherein the linker is a branched or unbranched carbon chain comprising no more than 30 carbons.

15. The kit of claim 14 wherein the linker comprises (CH 2 CH 2 O) y and y=2 to 8.

16. The kit of claim 12 , wherein X is Cl or Br.

17. The kit of claim 12 , wherein said solid support is a magnetic particle, a membrane, glass, cellulose, or a well of a multiwell plate.

18. The kit of claim 12 , wherein the polypeptide of claim 1 also comprises a protein of interest.

19. The kit of claim 18 , wherein A is (CH 2 ) n and n=4 to 10.

20. The kit of claim 18 , wherein the linker is a branched or unbranched carbon chain comprising no more than 30 carbons.

21. The kit of claim 20 , wherein the linker comprises (CH 2 CH 2 O) y and y=2 to 8.

22. The kit of claim 18 , wherein X is Cl or Br.

23. The kit of claim 18 , wherein said solid support is a magnetic particle, a membrane, glass, cellulose, or a well of a multiwell plate.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2017
From: DARZINS, ALDIS; ENCELL, LANCE P.; FRIEDMAN OHANA, RACHEL; OTTO, PAUL; VIDUGIRIS, GEDIMINAS; WOOD, KEITH V.; WOOD, MONIKA G.; ZIMMERMAN, KRIS; SLATER, MICHAEL R.; QIN ZHAO, KATE
To: PROMEGA CORPORATION
Reel/Frame 041341/0599 →